The level of sulfo-Le a (SO 3 -3Galβ β β β1-3(Fucα α α α1-4)GlcNAc) epitope recognized by monoclonal antibody (mAb) 91.9H in hepatic metastasis of colon carcinoma is known to be lower than at the primary sites. We examined 19 human colon carcinoma cell lines for their production of this epitope. Sixteen cell lines were found to produce high M r components that metabolically incorporated [ Colonic epithelial cells are known to produce sulfated mucins that can be identified by high iron diamine histochemical staining.
Colonic epithelial cells are known to produce sulfated mucins that can be identified by high iron diamine histochemical staining.
1) The presence of colonic sulfomucins was also revealed by metabolic incorporation of [ 35 S]sulfate. Similar sulfated high M r components are found in colon carcinoma tissues to a much smaller extent.
2) Synthesis of sulfomucins by metastatic cells was at a lower level than in tumors at primary sites. Filipe and coworkers 3, 4) also reported that there is a decrease in sulfomucin production during colonic carcinogenesis. The molecular and cellular basis for such variation of sulfated products by colon carcinoma cells is not well understood.
We previously prepared mAb 91.9H using sulfomucin partially purified from normal colonic mucosa. 5) This mAb reacted with high M r components from extracts of normal mucosa, colorectal primary carcinoma, and metastasis, in that order of magnitude. [5] [6] [7] [8] Moreover, immunohistochemical studies using mAb 91.9H showed that expression of sulfomucins decreased with increasing depth of invasion of colon carcinomas. 9) Vavasseur and co-workers 10) reported that human colon carcinoma cells with high reactivity to 91.9H were less tumorigenic in nude mice than cells with low reactivity to 91.9H. The epitope structure for mAb 91.9H was shown to contain sulfated groups, at least in normal colonic mucins. 7) Further investigation using oligosaccharides with defined structures indicated that the epitope structure for mAb 91.9H involves sulfo-Le a carbohydrate chains. 11, 12) In the present study, at least 8 out of 19 human colon carcinoma cell lines were found to be reactive with mAb 91.9H specific for sulfo-Le a in high M r components. The LS174T cell line was chosen as a model to evaluate further the importance of O-linked carbohydrate chains as a backbone in the epitope for mAb 91.9H. The present paper shows that sulfo-Le a antigen was expressed on the major high-molecular-weight sulfated glycoprotein produced by LS174T cells in a sulfated O-linked carbohydrate chain-specific manner. When transplanted into nude 3 To whom correspondence should be addressed. Abbreviations used: BSA, bovine serum albumin; Bzl-GalNAc, benzyl-N-acetyl-α-D-galactosaminide; DMEM/F12, 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F-12 medium; EDTA, ethylenediaminetetraacetate; Le a , Galβ1-3(Fucα1-4)GlcNAc; mAb, monoclonal antibody; M r , relative molecular mass; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate-buffered saline; PVDF, polyvinylidene difluoride; SDS, sodium dodecyl sulfate; sulfo-Le a , SO 3 -3Galβ1-3(Fucα1-4)GlcNAc.
mice, these cells appeared to express the sulfo-Le a antigen at the primary site, but the expression appeared to be suppressed in metastatic tumors in the liver. 4 -radiolabeled materials were identified by a BAS-2000 imaging analyzer. In some cases, membranes were incubated overnight in blocking solution from a Digoxigenin Detection Kit (Boehringer Mannheim Biochemica, Indianapolis, IN) at 4°C, followed by incubation with ascitic fluid containing mAb 91.9H diluted at 1:1000 in 50 mM citrate buffer (pH 5.5) containing 0.5% BSA and 0.1% Tween 20 at room temperature for 2 h with gentle shaking. The membranes were washed three times with 50 mM citrate buffer (pH 5.5) containing 0.1% Tween 20, then incubated at room temperature with anti-mouse Ig-digoxigenin, F(ab′)2-fragment (Boehringer Mannheim GmbH, Mannheim, Germany) diluted at 1:30 in 50 mM citrate buffer (pH 5.5) containing 0.1% Tween 20 for 1 h. Glycoproteins were visualized with a Digoxigenin Detection Kit (Boehringer Mannheim GmbH).
MATERIALS AND METHODS

Cell lines
Treatments of cells with inhibitors of sulfation or extension of O-linked carbohydrate chains
To block the sulfation of carbohydrate residues, 1×10 7 LS174T cells in a 100-cm dish were incubated overnight, then the medium was switched to 5 ml of [
35 S]sulfate-labeling medium or [
14 C]threonine-labeling medium containing 0 or 50 mM sodium chlorate and incubation was continued for another 48 h. 19) For the inhibition of O-glycosylation, the medium was changed to 5 ml of [ 35 S]sulfate-labeling medium or [
14 C]threonine-labeling medium containing 4 mM Bzl-GalNAc (Sigma, St. Louis, MO) and incubation was continued for another 48 h. The total protein concentration of each lysate was adjusted to 9.5 mg/ml by using a BCA protein assay kit. The lysates were heated at 100°C for 5 min to denature proteins, then centrifuged at 15,000 rpm for 15 min. Aliquots (38 µl) of the supernatants were loaded in each lane, separated by SDS-PAGE, and electroblotted onto a membrane, and the radioactivity levels associated with high M r components were compared. Immunohistochemical analysis of LS174T cells growing in vivo after orthotopic transplantation Cells were harvested by treatment with 0.02% EDTA and 0.05% trypsin. Viable single cells (1×10 6 cells in 50 µl of Hanks' solution) were injected into the subserosal space of the cecum of anesthetized athymic BALB/c nude mice (5 weeks old, male) (Japan SLC Inc., Shizuoka). Nine mice were used. Six weeks later, the mice were killed by administration of an overdose of pentobarbital. All had tumors at the site of injection and 4 had multiple liver metastases. Tumors at the site of transplantation (3 specimens) and those growing in the liver (4 specimens) were removed, fixed in 4% paraformaldehyde and processed for histochemical examinations. Four-micrometer sections were prepared and deparaffined sections were coated with PBS containing 2% normal goat serum and 3% BSA at room temperature for 10 min. The sections were then incubated with antibodies. Hybridoma culture supernatant was used for mAb 91.9H. mAb 7LE, obtained from Seikagaku Co., Ltd., was used at 10 µg/ml. As a control, mouse IgG was used at 10 µg/ml. Incubations were performed at room temperature for 40 min. Unbound antibodies were removed by washing 5 times with PBS for 3 min each. The sections were incubated with alkaline phos- The cell lysates were separated by SDS-PAGE on 4% gels and binding of mAb 91.9H (specific for sulfo-Le a carbohydrate chains) was examined by western blotting analysis. Among 16 cell lines which produced sulfated macromolecules resistant to heparitinase I and chondroitinase ABC, at least 8 cell lines, HCCP-2998, LS174T, GEO, CBS, DLD-1, HCT116, SW480, and HCC-M1544 produced the epitope for mAb 91.9H (Fig. 1B) . Table I shows the histological types of carcinomas from which cell lines were derived.
21) All 4 cell lines derived from well-differentiated tumor tissues, HCCP-2998, LS174T, GEO, and CBS, reacted strongly with mAb 91.9H. The apparent M r of the major component reactive with this mAb varied among different cell lines. Electrophoretic migration of components having reactivity with mAb 91.9H also suggested that not all sulfated mucins contained sulfo-Le a epitopes. A sulfated component having an apparent M r 900,000 that was reactive with mAb 91.9H was observed with HCCP-2998, LS174T, GEO, and CBS cells. Diffuse multiple bands were also observed with M r values ranging between 100,000 and 500,000.
Inhibition of biosynthesis of LS174T sulfomucins with inhibitors of sulfation or extension of O-linked carbohydrate chains of mucins A colon carcinoma cell line
LS174T was used as a model to investigate the nature of the sulfo-Le a antigen recognized by mAb 91.9H. Sodium chlorate is a known inhibitor of protein and carbohydrate sulfation. 19, 22) Aryl-N-acetyl-galactosaminides were initially used as potential competitors of the extending glycosylation of GalNAc residues linked to the core protein in LS174T cell lines.
23) Thus, we tested the effects of these compounds on mucin sulfation and biosynthesis of the mAb 91.9H epitope. As shown in Fig. 2A , both chlorate treatment and Bzl-GalNAc treatment significantly reduced the incorporation of [ 35 S]sulfate into high M r glycoprotein. To examine whether these treatments influence the biosynthetic rate of the polypeptide portion of mucins by LS174T cells, cells were metabolically labeled with [ 14 C]threonine and treated with sodium chlorate or BzlGalNAc under the same conditions as described above. Fig. 2B shows the radioactivity associated with high M r components electroblotted on the membrane. The results 14 C]threonine-labeled materials was tested on the same membrane, as shown in Fig. 2B. Fig. 2C illustrates the result of this western blotting analysis. The amount of mAb 91.9H bound to an area corresponding to the position of sulfomucins was significantly smaller when the cells were treated with sodium chlorate, indicating that biosynthesis of sulfo-Le a antigen is blocked by chlorate. A decrease in the amount of mAb 91.9H binding was also observed when LS174T cells were treated with Bzl-GalNAc. Because Bzl-GalNAc was shown to inhibit the extension of O-linked carbohydrate chains in LS174T cells, 23) these results strongly suggested that the sulfo-Le a epitope in high-molecular-weight glycoproteins is carried predominantly by O-linked carbohydrate chains in these cells. It is not known whether O-glycans predominantly carry sulfoLe a epitopes in other colon carcinoma cell lines expressing this epitope. Immunohistochemical analysis of the mAb 91.9H epitope in LS174T cells growing in nude mice LS174T cells were orthotopically transplanted into the subserosal space of the cecum in nude mice. All 9 mice used had tumors at the site of injection and 4 mice had liver metastases. Three primary tumors and 4 metastatic foci were examined to evaluate the immunohistochemical localization of binding sites for mAb 91.9H (Fig. 3) . When tumors in the cecum were examined, binding of mAb 91.9H was detected only to LS174T human colon carcinoma cells. Epithelial cells of the mouse cecum were not stained. LS174T cells growing in the primary tissues contained >10% cells that reacted with mAb 91.9H. However, not all of the LS174T cells reacted. Thus, the expression of sulfo-Le a carbohydrate chains in LS174T cells growing in vivo seemed to be partially suppressed. In the liver metastases, carcinoma cells rarely reacted with mAb 91.9H (Fig. 3f) . Interestingly, the nonsulfated counterpart of sulfo-Le a , the Le a epitope, revealed by mAb 7LE, was detected both at the primary tumors and in liver metastases (Fig. 3, g and h) . These results suggested that sulfation of type 1 precursor carbohydrate chains was suppressed when LS174T human colon carcinoma cells were growing in the liver in nude mice. Such differences in the staining of primary tumors and metastases were also observed when DLD-1 cells were orthotopically transplanted, though the incidence of metastases was very low. However, the intensity of high iron diamine staining of LS174T cells growing at the primary site was very low and the level was similar to that in the metastatic foci (Fig. 3, a and b) . Other carbohydrate epitopes that were decreased in the metastatic foci of LS174T cells are sialyl-Le a (mAb CA19-9) and sialyl-Le X (mAb KM93). Carbohydrate epitopes that were increased or unchanged in the metastatic foci are Le b , Le X and Le Y (data not shown).
DISCUSSION
Recently, we have found using oligosaccharides and glycolipids with defined structures that the epitope of mAb 91.9H is sulfo-Le a carbohydrate chains. 11, 12) However, the molecular basis for the decreased expression of this epitope in metastatic foci compared to the cells in primary sites was not previously known. When sulfate incorporation and mAb 91.9H reactivity to macromolecules of 19 human colon carcinoma cell lines were compared, 8 out of 16 cell lines, which incorporated sulfate groups into high M r glycoproteins, produced components reactive with mAb 91.9H. The relative intensity of the binding did not correspond to the degree of sulfate incorporation, confirming that this antibody does not recognize all sulfated glycoproteins. Among cell lines derived from a moderately to poorly differentiated primary tumor, only DLD-1 cells produced sulfated high M r components apparently reactive with mAb 91.9H. Few cell lines derived from poorly differentiated primary tumor or metastasis produced sulfated components. These components were only weakly reactive with mAb 91.9H, indicating that there is a weak but significant association between the sulfo-Le a epitope and the status of differentiation of colon carcinoma cells.
In our previous work, cell surface expression of sialylLe X and sialyl-Le a antigens was examined in these 19 human colon carcinoma cell lines by flow-cytometric analysis. 24) Sialyl-Le a was always detected on the cells expressing mAb 91.9H epitopes. Therefore, type 1 chains on mucin backbones seem to be converted into both sulfated and sialylated forms in these cells. Sulfated Le X was recently reported to comprise the major carbohydrate chains in mucin glycoproteins of a variant of LS174T cells. 25) Thus, LS174T cells seem to have a capacity to synthesize sulfo-3Galβ1-4(Fucα1-3)GlcNAc and sulfo3Galβ1-3(Fucα1-4)GlcNAc.
The core polypeptide of normal colonic sulfomucin was previously proposed to be encoded by the MUC2 gene. 7) This hypothesis, however, might need to be reevaluated as far as colon carcinoma cell lines are concerned, because our studies on the mucin core peptide mRNA products detected by reverse transcription-polymerase chain reaction in 19 human colon carcinoma cell lines indicated that some cell lines expressing sulfomucin recognized by mAb 91.9H did not produce the MUC2 mucin core polypeptide. 24) Thus, a sulfo-Le a epitope might be expressed on several different mucin core polypeptide backbones.
Immunohistochemical studies on LS174T cells transplanted into nude mice indicated that the sulfo-Le a epitope recognized by mAb 91.9H was expressed at the site of orthotopic transplantation. The level of antibody binding was much lower in hepatic metastasis than in the tumor tissue at the site of initial transplantation in the cecum. These patterns are consistent with the antibody binding profiles observed with clinical materials. [5] [6] [7] [8] [9] We are currently conducting additional studies to clarify whether the downregulation of the sulfo-Le a epitopes in LS174T tumors growing in the liver of recipient mice was due to the selective growth of sulfo-Le a -negative populations. Alternatively, the expression of sulfo-Le a could be downregulated through a paracrine mechanism in the liver. It would be of particular interest to see if the same phenomenon is observed with SW480 and HCC-M1544 cells, because they were derived from the metastatic region of colon carcinomas. Down-regulation of carbohydrate epitopes by microenvironmental factors in the liver was previously observed with the sialyl Le X carbohydrate antigens expressed by HT-29 human colon carcinoma cells. 26) Changes in sulfomucins induced by nonmalignant diseases such as cystic fibrosis and ulcerative colitis have also been documented. [27] [28] [29] Their causal relationship to the pathogenesis of these diseases has not been established. Partial carbohydrate structures of sulfomucins were previously reported in tracheobronchial mucins or respiratory mucins from cystic fibrosis patients. [30] [31] [32] [33] [34] It is not known whether these sulfomucins contain sulfo-Le a epitopes. The biological functions of sulfo-Le a carbohydrate chains in relation to the behavior of colon carcinoma cells are not known, though some reports have indicated that sulfo-Le a and other sulfated chains are directly recognized by L-selectin, E-selectin, or P-selectin. [35] [36] [37] [38] [39] Therefore, adhesive behavior of cells expressing sulfo-Le a carbohydrate chains recognized by mAb 91.9H will be an interesting subject for further investigations. (Received June 17, 1998 /Revised September 14, 1998 /Accepted September 21, 1998 
